Eli Cost Of Revenue from 2010 to 2024

LLY Stock  USD 778.18  3.28  0.42%   
Eli Lilly Cost Of Revenue yearly trend continues to be fairly stable with very little volatility. Cost Of Revenue will likely drop to about 3.6 B in 2024. During the period from 2010 to 2024, Eli Lilly Cost Of Revenue regression line of annual values had r-squared of  0.25 and arithmetic mean of  5,102,988,564. View All Fundamentals
 
Cost Of Revenue  
First Reported
1989-06-30
Previous Quarter
1.9 B
Current Value
1.7 B
Quarterly Volatility
498.5 M
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Eli Lilly financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Eli main balance sheet or income statement drivers, such as Depreciation And Amortization of 994.5 M, Interest Expense of 327.9 M or Total Revenue of 35.8 B, as well as many exotic indicators such as Short Term Coverage Ratios of 0.58, Price Earnings Ratio of 105 or Price To Sales Ratio of 16.15. Eli financial statements analysis is a perfect complement when working with Eli Lilly Valuation or Volatility modules.
  
This module can also supplement Eli Lilly's financial leverage analysis and stock options assessment as well as various Eli Lilly Technical models . Check out the analysis of Eli Lilly Correlation against competitors.

Latest Eli Lilly's Cost Of Revenue Growth Pattern

Below is the plot of the Cost Of Revenue of Eli Lilly And over the last few years. Cost of Revenue is found on Eli Lilly And income statement and represents the costs associated with goods and services Eli Lilly provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities. It is Eli Lilly's Cost Of Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Eli Lilly's overall financial position and show how it may be relating to other accounts over time.
Cost Of Revenue10 Years Trend
Slightly volatile
   Cost Of Revenue   
       Timeline  

Eli Cost Of Revenue Regression Statistics

Arithmetic Mean5,102,988,564
Geometric Mean4,765,496,062
Coefficient Of Variation28.65
Mean Deviation947,875,815
Median5,037,200,000
Standard Deviation1,462,199,980
Sample Variance2138028.8T
Range6.3B
R-Value0.50
Mean Square Error1720127T
R-Squared0.25
Significance0.06
Slope164,433,569
Total Sum of Squares29932403T

Eli Cost Of Revenue History

20243.6 B
20236.6 B
20226.6 B
20217.3 B
20205.5 B
20194.7 B
20184.7 B

About Eli Lilly Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Eli Lilly income statement, its balance sheet, and the statement of cash flows. Eli Lilly investors use historical funamental indicators, such as Eli Lilly's Cost Of Revenue, to determine how well the company is positioned to perform in the future. Although Eli Lilly investors may use each financial statement separately, they are all related. The changes in Eli Lilly's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Eli Lilly's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Eli Lilly Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Eli Lilly. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2024
Cost Of Revenue6.6 B3.6 B

Eli Lilly Investors Sentiment

The influence of Eli Lilly's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Eli. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Eli Lilly's public news can be used to forecast risks associated with an investment in Eli. The trend in average sentiment can be used to explain how an investor holding Eli can time the market purely based on public headlines and social activities around Eli Lilly And. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Eli Lilly's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Eli Lilly's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Eli Lilly's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Eli Lilly.

Eli Lilly Implied Volatility

    
  31.31  
Eli Lilly's implied volatility exposes the market's sentiment of Eli Lilly And stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Eli Lilly's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Eli Lilly stock will not fluctuate a lot when Eli Lilly's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Eli Lilly in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Eli Lilly's short interest history, or implied volatility extrapolated from Eli Lilly options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Eli Lilly And offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Eli Lilly's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Eli Lilly And Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Eli Lilly And Stock:
Check out the analysis of Eli Lilly Correlation against competitors.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Complementary Tools for Eli Stock analysis

When running Eli Lilly's price analysis, check to measure Eli Lilly's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eli Lilly is operating at the current time. Most of Eli Lilly's value examination focuses on studying past and present price action to predict the probability of Eli Lilly's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eli Lilly's price. Additionally, you may evaluate how the addition of Eli Lilly to your portfolios can decrease your overall portfolio volatility.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
FinTech Suite
Use AI to screen and filter profitable investment opportunities
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Is Eli Lilly's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eli Lilly. If investors know Eli will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eli Lilly listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.13
Dividend Share
4.52
Earnings Share
5.81
Revenue Per Share
37.908
Quarterly Revenue Growth
0.281
The market value of Eli Lilly And is measured differently than its book value, which is the value of Eli that is recorded on the company's balance sheet. Investors also form their own opinion of Eli Lilly's value that differs from its market value or its book value, called intrinsic value, which is Eli Lilly's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eli Lilly's market value can be influenced by many factors that don't directly affect Eli Lilly's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Eli Lilly's value and its price as these two are different measures arrived at by different means. Investors typically determine if Eli Lilly is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eli Lilly's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.